GlaxoSmithKline PLC banner

GlaxoSmithKline PLC
LSE:GSK

Watchlist Manager
GlaxoSmithKline PLC Logo
GlaxoSmithKline PLC
LSE:GSK
Watchlist
Price: 1 883 GBX 0.35%
Market Cap: £76.4B

Intrinsic Value

The intrinsic value for GlaxoSmithKline PLC (GSK) under the Base Case is 1 882.78 GBX. Compared with the current market price of 1 883 GBX, the stock appears Fairly Valued .

Based on two methods:

DCF suggests undervaluation, while multiples suggest overvaluation.

GSK Intrinsic Value
1 882.78 GBX
Fairly Valued
Intrinsic Value
Price GBX1 883
Bear Case
Base Case
Bull Case
Monitor GSK
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value GBX1 506.22
Get notified when the price drops into your buy zone
Current Price GBX1 883
Intrinsic Value GBX1 882.78
Margin of Safety 20% GBX1 506.22
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about GSK?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is GSK valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for GlaxoSmithKline PLC.

Explain Valuation
Alternatives to GSK

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one GSK stock?

The intrinsic value for GlaxoSmithKline PLC (GSK) under the Base Case is 1 882.78 GBX.

Is GSK stock undervalued or overvalued?

Compared with the current market price of 1 883 GBX, the stock appears Fairly Valued .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett